COLRAcinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets
Multidrug-Resistant (MDR) and Extensively Drug Resistant (XDR) Acinetobacter baumannii (Ab) represent a serious cause of healthcare-associated infections worldwide. Currently, the available treatment options are very restricted and colistin-based therapies are last-line treatments of these infection...
Main Authors: | Viviana Cafiso, Stefano Stracquadanio, Flavia Lo Verde, Veronica Dovere, Alessandra Zega, Giuseppe Pigola, Jesús Aranda, Stefania Stefani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.03075/full |
Similar Items
-
Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
by: Burke A. Cunha, et al.
Published: (2010-01-01) -
Activity of Antimicrobial Combinations Against Extensively Drug-Resistant Acinetobacter baumannii as Determined by Checkerboard Method and E-test
by: Sunee Limsrivanichakorn, et al.
Published: (2020-03-01) -
Antimicrobial Resistance Pattern of Acinetobacter baumannii Strains Isolated from Intensive Care Unit Patients
by: Azad Khaledi, et al.
Published: (2018-11-01) -
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy
by: Viviana Cafiso, et al.
Published: (2019-01-01) -
Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
by: Jiawei Zeng, et al.
Published: (2017-08-01)